Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 20;19(3):1116.
doi: 10.3390/ijerph19031116.

Obesity and Thyroid Cancer Risk: An Update

Affiliations
Review

Obesity and Thyroid Cancer Risk: An Update

Fabiana Franchini et al. Int J Environ Res Public Health. .

Abstract

Thyroid cancer (TC) is the most common endocrine malignancy worldwide and its incidence has increased dramatically in recent years. In parallel, the prevalence of overweight and obesity has also increased, suggesting a possible link between these two diseases. Indeed, low-grade chronic inflammation, altered cytokine levels, insulin resistance, oxidative stress, and hormonal changes that occur in obese patients are all factors that contribute to the occurrence and growth of TC. In this review, the most recent evidence supporting the potential role of the mechanisms linking obesity to TC will be discussed.

Keywords: cytokines; estrogens; insulin; insulin resistance; obesity; overweight; oxidative stress; risk factors; thyroid carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the main factors linking obesity to thyroid cancer. Diet is the most important factor in the development of obesity, but also plays an important role in influencing TC risk, either directly (i.e.,: iodine deficiency, endocrine disruptors [8]) or through indirect mechanisms (i.e.,: certain pro-inflammatory foods [39]). Obesity promotes additional molecular effects that contribute to induction, growth, and proliferation of TCs. IGFs: insulin-like growth factors.

Similar articles

Cited by

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Zaballos M.A., Santisteban P. Key signaling pathways in thyroid cancer. J. Endocrinol. 2017;235:R43–R61. doi: 10.1530/JOE-17-0266. - DOI - PubMed
    1. Prete A., Borges de Souza P., Censi S., Muzza M., Nucci N., Sponziello M. Update on Fundamental Mechanisms of Thyroid Cancer. Front. Endocrinol. 2020;11:102. doi: 10.3389/fendo.2020.00102. - DOI - PMC - PubMed
    1. Wirth S., Syleouni M.E., Karavasiloglou N., Rinaldi S., Korol D., Wanner M., Rohrmann S. Incidence and mortality trends of thyroid cancer from 1980 to 2016. Swiss Med. Wkly. 2021;151:w30029. doi: 10.4414/smw.2021.w30029. - DOI - PubMed
    1. Agate L., Lorusso L., Elisei R. New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. J. Endocrinol. Investig. 2012;35:3–9. - PubMed